NCT00371956View on ClinicalTrials.gov

Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chronic Corticosteroid Therapy

PHASE4CompletedINTERVENTIONAL

Enrollment

114

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions

Osteoporosis

Interventions

DRUG

raloxifene

60mg/day

DRUG

placebo

tab 1 daily

Trial Locations (1)

Unknown

Tuen Mun Hospital, Hong Kong

All Listed Sponsors

collaborator

Eli Lilly and Company

INDUSTRY

lead

Tuen Mun Hospital

OTHER_GOV

NCT00371956 - Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chronic Corticosteroid Therapy | Biotech Hunter | Biotech Hunter